enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Cabotegravir/rilpivirine - Wikipedia

    en.wikipedia.org/wiki/Cabotegravir/rilpivirine

    [3] [4] In the European Union, the combination is indicated for maintenance treatment of adults who have undetectable HIV levels in the blood (viral load less than 50 copies/mL) with their current antiretroviral treatment, and when the virus has not developed resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) and integrase ...

  3. GSK's injectable HIV drug shows promise over daily pills - AOL

    www.aol.com/news/gsks-injectable-hiv-drug-shows...

    The lack of consistent adherence is a common reason why some people living with HIV struggle to keep the virus in check, GSK said. GSK's injectable HIV drug shows promise over daily pills Skip to ...

  4. Cabotegravir - Wikipedia

    en.wikipedia.org/wiki/Cabotegravir

    Cabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva. [8] [14]

  5. GSK says within weeks of resubmitting HIV injection Cabenuva

    www.aol.com/news/gsk-says-within-weeks...

    GlaxoSmithKline's HIV business ViiV is within weeks of resubmitting its request for approval of its long-acting injection Cabenuva to U.S. drug regulators, ViiV's head of research said on Thursday.

  6. List of antiretroviral fixed-dose combinations - Wikipedia

    en.wikipedia.org/wiki/List_of_antiretroviral...

    Antiretroviral drugs are used to manage HIV/AIDS. Multiple antiretroviral drugs are often combined into a single pill in order to reduce pill burden. Some of these combinations are complete single-tablet regimens; the others must be combined with additional pills to make a treatment regimen.

  7. GSK lifts growth target for HIV business on demand for long ...

    www.aol.com/news/gsk-lifts-growth-ambitions-hiv...

    The HIV business, the focus of a GSK's capital markets day on Thursday, is now targeting annual rates of sales growth of between 6% and 8%, to reach between 6 billion pounds ($7.31 billion) and 7 ...

  8. Rilpivirine - Wikipedia

    en.wikipedia.org/wiki/Rilpivirine

    Rilpivirine, sold under the brand names Edurant and Rekambys, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. [5] [6] It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.

  9. Our 2022 HIV Treatment Guide is Here! - AOL

    www.aol.com/news/2022-hiv-treatment-guide...

    Due to the amazing advancements in HIV treatment over the past 40 years, people living with the virus are now enjoying happier, healthier, and longer lives than ever before. In fact, thanks to the ...